Home › Idiopathic Pulmonary Fibrosis › Connecticut › New Haven
Idiopathic Pulmonary Fibrosis clinical trials in New Haven, CT
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
RecruitingPhase 2
- Yale University, New Haven
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Yale University School of Medicine, New Haven
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Yale University, New Haven
Idiopathic Pulmonary Fibrosis trials in other cities
- Birmingham, AL9 studies
- New York City, NY8 studies
- Kansas City, KS7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA7 studies
- Chicago, IL6 studies
- Aurora, CO6 studies
- Durham, NC6 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Charleston, SC5 studies
- Houston, TX5 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.